David J Nutt

Prescribing antidepressants post Cipriani et al
J Psychopharmacol 2009 23: 865-866. [PDF] [References] [Request Permission]  

D. Nutt, F. Mandel, and F. Baldinetti

Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model
J Psychopharmacol 2009 23: 867-873. [Abstract] [PDF] [References] [Request Permission]  

S. Englisch, U. Knopf, B. Scharnholz, A. Kuwilsky, M. Deuschle, and M. Zink

Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial
J Psychopharmacol 2009 23: 875-882. [Abstract] [PDF] [References] [Request Permission]  

F. Caputo, S. Francini, M. Stoppo, F. Lorenzini, T. Vignoli, A. Del Re, C. Comaschi, L. Leggio, G. Addolorato, G. Zoli, and M. Bernardi

Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study
J Psychopharmacol 2009 23: 883-890. [Abstract] [PDF] [References] [Request Permission]  

JG Goekoop, RFP de Winter, R. Wolterbeek, P. Spinhoven, FG Zitman, and VM Wiegant

Reduced cooperativeness and reward-dependence in depression with above-normal plasma vasopressin concentration
J Psychopharmacol 2009 23: 891-897. [Abstract] [PDF] [References] [Request Permission]  

PE Harrison-Read

Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of data from the archives and implications for improved antimanic treatments
J Psychopharmacol 2009 23: 899-907. [Abstract] [PDF] [References] [Request Permission]  

BC Kleijer, RJ van Marum, ACG Egberts, PAF Jansen, W. Knol, and ER Heerdink

Risk of cerebrovascular events in elderly users of antipsychotics
J Psychopharmacol 2009 23: 909-914. [Abstract] [PDF] [References] [Request Permission]  

V. Medved, MR Kuzman, N. Jovanovic, J. Grubisin, and T. Kuzman

Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up
J Psychopharmacol 2009 23: 915-922. [Abstract] [PDF] [References] [Request Permission]  

F. Hasler, E. Studerus, K. Lindner, S. Ludewig, and FX Vollenweider

Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA
J Psychopharmacol 2009 23: 923-935. [Abstract] [PDF] [References] [Request Permission]  

YC Liu, CL Huang, PL Wu, YC Chang, CH Huang, and HY Lane

Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia
J Psychopharmacol 2009 23: 937-943. [Abstract] [PDF] [References] [Request Permission]  

N. Kokras, K. Antoniou, C. Dalla, S. Bekris, M. Xagoraris, DH Ovestreet, and Z. Papadopoulou-Daifoti

Sex-related differential response to clomipramine treatment in a rat model of depression
J Psychopharmacol 2009 23: 945-956. [Abstract] [PDF] [References] [Request Permission]  

A. Wheeler, V. Humberstone, and G. Robinson

Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
J Psychopharmacol 2009 23: 957-965. [Abstract] [PDF] [References] [Request Permission]  

C. Moret, M. Isaac, and M. Briley

Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
J Psychopharmacol 2009 23: 967-974. [Abstract] [PDF] [References] [Request Permission]  

G. Esquivel, O. Fernández-Torre, KRJ Schruers, LLW Wijnhoven, and EJL Griez

The effects of opioid receptor blockade on experimental panic provocation with CO 2
J Psychopharmacol 2009 23: 975-978. [Abstract] [PDF] [References] [Request Permission]  

AW Zuardi, Jas Crippa, JEC Hallak, JP Pinto, MHN Chagas, GGR Rodrigues, SM Dursun, and V. Tumas

Cannabidiol for the treatment of psychosis in Parkinson’s disease
J Psychopharmacol 2009 23: 979-983. [Abstract] [PDF] [References] [Request Permission]  

MF Juruena, CS Gama, M. Berk, and PS Belmonte-de-Abreu

Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series
J Psychopharmacol 2009 23: 985-987. [Abstract] [PDF] [References] [Request Permission]  

SC Jamison and S. Vasudeva

A 60-year-old woman with agitation and psychosis following ingestion of dextromethorphan and opioid analgesics
J Psychopharmacol 2009 23: 989-991. [Abstract] [PDF] [References] [Request Permission]  

SS Eker, A. Sarandol, C. Akkaya, EY Sivrioglu, and S. Kirli

The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases
J Psychopharmacol 2009 23: 993-996. [Abstract] [PDF] [References] [Request Permission]  

KS Reid

Positive interference of the analgesic nefopam in the urine immunoassay for benzodiazepines in a secure setting
J Psychopharmacol 2009 23: 997. [Abstract] [PDF] [References] [Request Permission]  

MA Ates, A. Algul, O. Gecici, UB Semiz, O. Yilmaz, and M. Gulsun

Olanzapine treatment in Jarisch-Herxheimer reaction due to neurosyphilis with dementia: a case report
J Psychopharmacol 2009 23: 999-1000. [Abstract] [PDF] [References] [Request Permission]  

M. Kuloglu, A. Caykoylu, O. Ekinci, and E. Yilmaz

Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report
J Psychopharmacol 2009 23: 1001-1003. [Abstract] [PDF] [References] [Request Permission]  

AJ Mitchell

Book Review: Clinical Guide to the Diagnosis and Treatment of Mental Disorders Michael First, Allam Tasman, Wiley, Price: £50
J Psychopharmacol 2009 23: 1005. [PDF] [Request Permission]  

Erratum
J Psychopharmacol 2009 23: 1006. [Abstract] [PDF] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.